Media Center
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan PRN Newswire Release • Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging biotechnology…
Read More
Ponce Aurora Appoints Former Estee Lauder Executive as Chief Commercial Officer Ahead of Longevity Product Launches
Ponce Aurora is developing consumer products powered by its proprietary MitoXcel™ Technology, the first information- and AI-driven mitochondrial-targeted geropeptides addressing a fundamental cause of aging. Appointment strengthens leadership team to drive market readiness for YUUTH- and…
Read More
Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
Read More
Pulmatrix and Eos merge to advance gerotherapeutics
Pulmatrix and Eos merge to advance gerotherapeutics
Read More
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan PRN Newswire Release • Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging biotechnology…
Read More

